Dortch John D, Oldenburg W Andrew, Farres Houssam, Rawal Bhupendra, McKinney J Mark, Paz-Fumagalli Ricardo, Hakaim Albert G
Mayo Clinic, Jacksonville, FL.
Mayo Clinic, Jacksonville, FL.
Ann Vasc Surg. 2014 Jul;28(5):1258-65. doi: 10.1016/j.avsg.2013.12.026. Epub 2014 Feb 8.
Long-term follow-up of patients with aortouniiliac (AUI) grafts is lacking in the current literature. The purpose of this study was to review the outcomes of endovascular aneurysm repair (EVAR) using commercially available AUI devices with femorofemoral bypass in patients whose aortoiliac anatomy was unfavorable for bifurcated repair.
A retrospective review of 35 patients from September 2000 to February 2012, who underwent EVAR with commercially manufactured AUI devices, was performed. These comprised 35 of 372 (9.4%) patients who underwent EVAR during that period. Patient records were reviewed to determine morbidity, mortality, and survival after AUI repair. Patients were followed at 1-, 3-, 6-, and 12-month intervals with computed tomography (CT) scans during each visit. Median follow-up was 40 months (range: 2-135 months).
Median age at surgery was 76 years (range: 60-93). The median preoperative aneurysm diameter was 57 mm (range: 45-71) and the median postoperative diameter was 53 mm (range: 29-80). Two type II endoleaks occurred on 1-month CT, whereas 10 endoleaks (type I [3], II [6], and III [1]) occurred during follow-up after 1 month. Migration of the stent graft occurred in 9% (n=3). Secondary procedures were required in 26% (n=9), whereas tertiary procedures were required in 3% (n=1). One patient required treatment for thrombosis of the iliac extension and 2 required treatment for thrombosis of the femorofemoral component. Mortality over the follow-up period was 34% (n=12) with no deaths occurring within 30 days.
High-risk patients who present with aortoiliac anatomy unsuitable for bifurcated stent graft placement should be offered AUI graft placement as a potential alternative to open repair.
目前文献中缺乏对主动脉单髂动脉(AUI)移植物患者的长期随访。本研究的目的是回顾使用市售AUI装置并进行股股旁路手术的血管内动脉瘤修复(EVAR)在主动脉髂动脉解剖结构不利于分叉修复的患者中的治疗结果。
对2000年9月至2012年2月期间接受市售AUI装置进行EVAR手术的35例患者进行回顾性研究。这35例患者占同期接受EVAR手术的372例患者中的35例(9.4%)。回顾患者记录以确定AUI修复后的发病率、死亡率和生存率。每次随访时,患者在1个月、3个月、6个月和12个月时接受计算机断层扫描(CT)检查。中位随访时间为40个月(范围:2 - 135个月)。
手术时的中位年龄为76岁(范围:60 - 93岁)。术前动脉瘤的中位直径为57 mm(范围:45 - 71 mm),术后中位直径为53 mm(范围:29 - 80 mm)。1个月时的CT检查发现2例II型内漏,而1个月后的随访期间出现10例内漏(I型[3例]、II型[6例]和III型[1例])。支架移植物移位的发生率为9%(n = 3)。26%(n = 9)的患者需要二次手术,3%(n = 1)的患者需要三次手术。1例患者需要治疗髂动脉延伸段血栓形成,2例患者需要治疗股股部件血栓形成。随访期间的死亡率为34%(n = 12),30天内无死亡发生。
对于主动脉髂动脉解剖结构不适合放置分叉型支架移植物的高危患者,应考虑将AUI移植物置入作为开放修复的潜在替代方案。